Ligand Pharmaceuticals Reports First Quarter Results
Ligand to Report First Quarter Results on May 10th
Ligand Partner Prism Pharmaceuticals to be Acquired by Baxter
Ligand Names Matthew W. Foehr Chief Operating Officer
Ligand to Present at the Citi 2011 Global Healthcare Conference on March 2
Ligand Announces Fourth Quarter and Full Year 2010 Consolidated Financial Results
Ligand Appoints John L. LaMattina to Board of Directors
Ligand to Report Fourth Quarter Results on February 15th
Ligand Acquires CyDex Pharmaceuticals
Ligand Forms Strategic Drug Development Alliance with Chiva Pharmaceuticals
Ligand Earns $1 Million Upfront Payment from Pfizer on Sublicensing of Tanaproget
Ligand Announces Positive Preclinical Data on Small Molecule Erythropoietin Receptor Agonists
Ligand Announces Presentation of Data from Multiple Studies of Dinaciclib by its Partner Merck at the ASH Annual Meeting
Ligand Reverse Stock Split Effective Today
